GlassScriptPhysician profile
Kerry S Green
NPI 1801835350
$2,591.74
in general payments reported to CMS, 2019-2025
43 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $335 · 2021: $555 · 2022: $263 · 2023: $414 · 2024: $429 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $265.35 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2, Proclaim |
| Glaxosmithkline, LLC. | $198.85 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $189.10 | 2019-2024 | Spravato, Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $150.42 | 2019-2023 | Xifaxan |
| Abbvie INC. | $149.04 | 2021-2023 | |
| Novo Nordisk INC | $132.36 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.83 | 2019-2024 | Jardiance |
| Astellas Pharma US INC | $102.63 | 2019-2025 | Veozah |
| Amgen INC. | $97.55 | 2021-2024 | Evenity, Prolia |
| Mylan Specialty L.P. | $87.64 | 2020-2023 | Yupelri |
| Boston Scientific Corporation | $87.02 | 2019-2025 | Watchman Flx |
| Allergan, INC. | $79.87 | 2019-2020 | |
| Dexcom, INC. | $66.69 | 2024-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $59.83 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Lucid Diagnostics INC. | $59.48 | 2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.